CLINICAL TRIALS PROFILE FOR SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID
✉ Email this page to a colleague
All Clinical Trials for SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02124447 ↗ | Single Center Comparison of 4 FDA Approved, Commercially Available Bowel Purgatives for Colonoscopy | Withdrawn | Medical College of Wisconsin | N/A | 2014-06-01 | This will be a 4-way comparison to prospectively evaluate the efficacy and patient tolerability of four commercially available bowel preparations among patients undergoing colonoscopy for screening and surveillance in a single tertiary academic medical center. |
| NCT03017235 ↗ | A Study Comparing the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution With PREPOPIK® for Colon Cleansing in Preparation for Colonoscopy | Completed | Ferring Pharmaceuticals | Phase 3 | 2017-02-20 | The purpose of this study is to compare the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution with PREPOPIK® for colon cleansing in adult subjects undergoing colonoscopy. |
| NCT03198221 ↗ | Comparison of Clenpiq vs Golytely Bowel Preparation | Terminated | Ferring Pharmaceuticals | Phase 4 | 2018-07-11 | This is a prospective randomized study which will be done at main campus Cleveland Clinic. The investigators will be comparing the colon cleansing by the Boston Bowel Preparation Scale in participants undergoing colonoscopy as an inpatient at our hospital. Participants will be randomized to the the standard of care (4 Liter polyethylene glycol based preparation) or a low volume bowel preparation (sodium picosulfate, a stimulant laxative, magnesium oxide and anhydrous citric acid (SP/MC)). Both agents will either be administered as full dose the evening before or as split-dose on the evening before and on the day of the procedure. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID
Condition Name
| Condition Name for SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID | |
| Intervention | Trials |
| Bowel Preparation | 1 |
| Bowel Preparation Solutions | 1 |
| Patients Undergoing Screening or Surveillance Colonoscopy | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID
Trials by Country
Clinical Trial Progress for SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID
Clinical Trial Phase
Clinical Trial Sponsors for SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID
Sponsor Name
| Sponsor Name for SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID | |
| Sponsor | Trials |
| Ferring Pharmaceuticals | 2 |
| The Cleveland Clinic | 1 |
| Hospital Universitari Vall d'Hebron Research Institute | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
